Pfizer TLZ 0.25 (Talzenna 0.25 mg)
Generic Name: talazoparib
Pill with imprint Pfizer TLZ 0.25 is White, Capsule-shape and has been identified as Talzenna 0.25 mg. It is supplied by Pfizer Inc..
Talzenna is used in the treatment of breast cancer and belongs to the drug class PARP inhibitors. Talzenna 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer TLZ 0.25
Talzenna
- Generic Name
- talazoparib
- Imprint
- Pfizer TLZ 0.25
- Strength
- 0.25 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Parp inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0296
More about Talzenna (talazoparib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: PARP inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.